BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22455007)

  • 1. Valproate in acute mania: is our practice evidence based?
    Vasudev K; Mead A; Macritchie K; Young AH
    Int J Health Care Qual Assur; 2012; 25(1):41-52. PubMed ID: 22455007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
    Müller-Oerlinghausen B; Retzow A; Henn FA; Giedke H; Walden J
    J Clin Psychopharmacol; 2000 Apr; 20(2):195-203. PubMed ID: 10770458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
    Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
    BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood stabilizer loading versus titration in acute mania: audit of clinical practice.
    Wheeler A; Robinson G; Fraser A
    Aust N Z J Psychiatry; 2008 Nov; 42(11):955-62. PubMed ID: 18941960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of oral loading of divalproex sodium in the treatment of acute mania.
    Martinez JM; Russell JM; Hirschfeld RM
    Depress Anxiety; 1998; 7(2):83-6. PubMed ID: 9614597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
    Samalin L; Llorca PM
    Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    Ouyang WC; Hsu MC; Yeh IN; Kuo CC
    Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G; Albert U; Salvi V; Mancini M; Bogetto F
    J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics.
    Reischies FM; Hartikainen J; Berghöfer AM
    Pharmacopsychiatry; 2002 Nov; 35(6):244-6. PubMed ID: 12518274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report.
    Alvarez P; Papaseit E; Pérez V; Bulbena A; Farré M
    Actas Esp Psiquiatr; 2019 Jan; 47(1):33-6. PubMed ID: 30724329
    [No Abstract]   [Full Text] [Related]  

  • 12. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
    Berwaerts J; Lane R; Nuamah IF; Lim P; Remmerie B; Hough DW
    J Affect Disord; 2011 Mar; 129(1-3):252-60. PubMed ID: 20947174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic evidence for manic episode].
    Terao T
    Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit.
    Goldspink R; Pumipi T; Dey S; Menkes DB
    Australas Psychiatry; 2020 Oct; 28(5):555-558. PubMed ID: 32586113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Valproate in the treatment of bipolar disorder].
    Rzewuska M
    Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
    Sekhar S; Kalra B; Mendhekar DN; Tekur U
    J Clin Pharmacol; 2010 Jun; 50(6):688-92. PubMed ID: 20075184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid reversal of corticosteroid-induced mania with sodium valproate: a case series of 20 patients.
    Roxanas MG; Hunt GE
    Psychosomatics; 2012; 53(6):575-81. PubMed ID: 23157995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
    Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L
    Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.